UFPT Stock Analysis: Buy, Sell, or Hold?
UFPT - UFP Technologies Inc
$237.25
0.34 (0.14%)
▲
5d:
-12.8%
30d:
+2.05%
90d:
+17.89%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 03, 2026
20d
Get Alerted When UFPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: UFPT is down 12.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: UFPT is down 12.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$351.98
Based on 8.3% avg growth
INTRINSIC VALUE TODAY
$218.55
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: UFPT is currently trading at $237.25, which is considered fair relative to its 30-day fair value range of $228.80 to $259.64. The stock's valuation (Forward PE: 20.3) is in line with its historical norms (20.3). Remarkably, the market is currently pricing in an annual earnings decline of 0.1% over the next few years. This pessimistic expectation contrasts with the company's recent 1.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, UFPT is in a uptrend. The price is currently testing key support at $233.36. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $324.50 (+36.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, UFPT is in a uptrend. The price is currently testing key support at $233.36. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $324.50 (+36.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$228.80 -
$259.64
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 36.8% below Wall St target ($324.50)
- WARNING: Recommendation downgraded due to -12.8% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$228.80 -
$259.64
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$233.36
Resistance Level
$279.49
Current Trend
Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.30
Wall Street Target
$324.50
(+36.8%)
Revenue Growth (YoY)
4.1%
Earnings Growth (YoY)
1.4%
Profit Margin
11.3%
Valuation Discount vs History
-0.1% cheaper
PE vs Historical
20.3 vs 20.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.1%
(market-implied from PE analysis)
1-Year Target
$237.01
(0%)
2-Year Target
$236.78
(0%)
3-Year Target
$236.54
(0%)
3-Yr Target (if PE normalizes)
(PE: 20→20)
$236.55
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 12.5%)
$362.85
(+53%)
Base:
(SPY PE: 20.3, Growth: 12.5%)
$338.18
(+43%)
Bear:
(PE: 17.3, Growth: 12.5%)
$287.46
(+21%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (20x PE) as earnings recover.
Trailing PE: 26.95 | Current EPS (TTM): $8.79
Bull Case
$346.50
(+46%)
Analyst growth 33.0%, PE expands to 29.7
Base Case
$315.00
(+33%)
Market implied 33.0%, PE stable at 27.0
Bear Case
$161.10
(-32%)
Severe decline -20.0%, PE contracts to 22.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 20.3 to 20.3
Stabilization Target:
$237.26
(+0.0%)
PE Expansion Potential:
+0.0%
Share & Embed Analysis
Last updated: July 13, 2026 6:01 PM ET
Data refreshes hourly during market hours. Next update: 7:01 PM
Data refreshes hourly during market hours. Next update: 7:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UFPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 65 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 63 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 57 HOLD |
